| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC10 |
| UNII: | DLG4EML025 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin 17A inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Spondylitis, Ankylosing | 3 | D013167 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Behcet Syndrome | 3 | D001528 | ClinicalTrials |
| Uveitis | 3 | D014605 | ClinicalTrials |
| Osteoarthritis | 3 | D010003 | ClinicalTrials |
| Hidradenitis Suppurativa | 3 | D017497 | ClinicalTrials |
| Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
| Lupus Nephritis | 3 | D008181 | ClinicalTrials |
| Graves Ophthalmopathy | 3 | D049970 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Dry Eye Syndromes | 2 | D015352 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Pyoderma | 2 | D011711 | ClinicalTrials |
| Lupus Erythematosus, Discoid | 2 | D008179 | ClinicalTrials |
| Tendinopathy | 2 | D052256 | ClinicalTrials |
| Polymyalgia Rheumatica | 2 | D011111 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Necrobiosis Lipoidica | 2 | D009335 | ClinicalTrials |
| Alopecia Areata | 2 | D000506 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Pityriasis Rubra Pilaris | 1 | D010916 | ClinicalTrials |
| Rosacea | 1 | D012393 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1229022-83-6 |
| ChEMBL | CHEMBL1743068 |
| FDA SRS | DLG4EML025 |
| Guide to Pharmacology | 8078 |
CONTENTS